PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product DNA extraction kit - Market size and forecast 2018-2023 RNA extraction kit - Market size and forecast 2018-2023 Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DRIVERS AND CHALLENGES Market drivers Market challenges PART 10: MARKET TRENDS PART 11: VENDOR LANDSCAPE Overview Landscape disruption PART 12: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Agilent Technologies Inc. Bio-Rad Laboratories Inc. Merck KGaA QIAGEN Thermo Fisher Scientific Inc. PART 13: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors   Exhibit 01: Years in consideration Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: DNA extraction kit - Market size and forecast 2018-2023 ($ millions) Exhibit 21: DNA extraction kit - Year-over-year growth 2019-2023 (%) Exhibit 22: RNA extraction kit - Market size and forecast 2018-2023 ($ millions) Exhibit 23: RNA extraction kit - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 29: North America - Year-over-year growth 2019-2023 (%) Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Europe - Year-over-year growth 2019-2023 (%) Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Asia - Year-over-year growth 2019-2023 (%) Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 35: ROW - Year-over-year growth 2019-2023 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Decision framework Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Agilent Technologies Inc. - Vendor overview Exhibit 46: Agilent Technologies Inc. - Business segments Exhibit 47: Agilent Technologies Inc. - Organizational developments Exhibit 48: Agilent Technologies Inc. - Geographic focus Exhibit 49: Agilent Technologies Inc. - Segment focus Exhibit 50: Agilent Technologies Inc. - Key offerings Exhibit 51: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 52: Bio-Rad Laboratories Inc. - Product segments Exhibit 53: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 54: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 55: Bio-Rad Laboratories Inc. - Segment focus Exhibit 56: Bio-Rad Laboratories Inc. - Key offerings Exhibit 57: Merck KGaA - Vendor overview Exhibit 58: Merck KGaA - Business segments Exhibit 59: Merck KGaA - Organizational developments Exhibit 60: Merck KGaA - Geographic focus Exhibit 61: Merck KGaA - Segment focus Exhibit 62: Merck KGaA - Key offerings Exhibit 63: QIAGEN - Vendor overview Exhibit 64: QIAGEN - Business segments Exhibit 65: QIAGEN - Organizational developments Exhibit 66: QIAGEN - Geographic focus Exhibit 67: QIAGEN - Segment focus Exhibit 68: QIAGEN - Key offerings Exhibit 69: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 70: Thermo Fisher Scientific Inc. - Business segments Exhibit 71: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 72: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 73: Thermo Fisher Scientific Inc. - Segment focus Exhibit 74: Thermo Fisher Scientific Inc. - Key offerings Exhibit 75: Validation techniques employed for market sizing Exhibit 76: List of abbreviations Exhibit 77: Definition of market positioning of vendors

Agilent Technologies Inc. Bio-Rad Laboratories Inc. Merck KGaA QIAGEN Thermo Fisher Scientific Inc.